Canada markets open in 8 hours 38 minutes

Hyloris Pharmaceuticals SA (HYL.BR)

Brussels - Brussels Delayed Price. Currency in EUR
Add to watchlist
11.700.00 (0.00%)
At close: 05:37PM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 327.60M
Enterprise Value 298.66M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)116.42
Price/Book (mrq)8.44
Enterprise Value/Revenue 106.13
Enterprise Value/EBITDA -39.56

Trading Information

Stock Price History

Beta (5Y Monthly) 0.56
52-Week Change 31.30%
S&P500 52-Week Change 327.84%
52 Week High 314.10
52 Week Low 310.60
50-Day Moving Average 311.80
200-Day Moving Average 312.16

Share Statistics

Avg Vol (3 month) 39.09k
Avg Vol (10 day) 3N/A
Shares Outstanding 528M
Implied Shares Outstanding 628M
Float 8N/A
% Held by Insiders 156.62%
% Held by Institutions 10.39%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-548.55%

Management Effectiveness

Return on Assets (ttm)-18.54%
Return on Equity (ttm)-33.95%

Income Statement

Revenue (ttm)2.81M
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)80.20%
Gross Profit (ttm)N/A
EBITDA -15.74M
Net Income Avi to Common (ttm)-15.76M
Diluted EPS (ttm)-0.56
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)30.7M
Total Cash Per Share (mrq)N/A
Total Debt (mrq)1.75M
Total Debt/Equity (mrq)4.51%
Current Ratio (mrq)5.09
Book Value Per Share (mrq)1.97

Cash Flow Statement

Operating Cash Flow (ttm)-12.73M
Levered Free Cash Flow (ttm)-7.78M